Evidence map›Paper›PMID 35335164›Full record

ReviewMolecules (Basel, Switzerland)2022

Recent Progress in Organic Solar Cells: A Review on Materials from Acceptor to Donor.

Yang Li, Wei Huang, Dejiang Zhao, Lu Wang, Zhiqiang Jiao, Qingyu Huang, Peng Wang, Mengna Sun, Guangcai Yuan

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yang LiBOE Technology Group Co., Ltd., Beijing 100176, China.
Wei HuangBOE Technology Group Co., Ltd., Beijing 100176, China.
Dejiang ZhaoBOE Technology Group Co., Ltd., Beijing 100176, China.
Lu WangBOE Technology Group Co., Ltd., Beijing 100176, China.
Zhiqiang JiaoBOE Technology Group Co., Ltd., Beijing 100176, China.
Qingyu HuangBOE Technology Group Co., Ltd., Beijing 100176, China.
Peng WangBOE Technology Group Co., Ltd., Beijing 100176, China.
Mengna SunBOE Technology Group Co., Ltd., Beijing 100176, China.
Guangcai YuanBOE Technology Group Co., Ltd., Beijing 100176, China.
BOE Technology Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last few decades, organic solar cells (OSCs) have drawn broad interest owing to their advantages such as being low cost, flexible, semitransparent, non-toxic, and ideal for roll-to-roll large-scale processing. Significant advances have been made in the field of OSCs containing high-performance active layer materials, electrodes, and interlayers, as well as novel device structures. Particularly, the innovation of active layer materials, including novel acceptors and donors, has contributed significantly to the power conversion efficiency (PCE) improvement in OSCs. In this review, high-performance acceptors, containing fullerene derivatives, small molecular, and polymeric non-fullerene acceptors (NFAs), are discussed in detail. Meanwhile, highly efficient donor materials designed for fullerene- and NFA-based OSCs are also presented. Additionally, motivated by the incessant developments of donor and acceptor materials, recent advances in the field of ternary and tandem OSCs are reviewed as well.

Indexed as

acceptordonororganic solar cellstandemternary

Identifiers

PMID35335164
PMCPMC8955087
OpenAlexW4220975328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.